Animal Vaccine Market

Animal Vaccine Market Study by Attenuated Live, Recombinant, DNA, Inactivated, and Subunit for Livestock Animals and Companion Animals from 2024 to 2034

Analysis of Animal/Veterinary Vaccine Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Animal Vaccine Market Outlook (2024 to 2034)

According to the recently revised analysis by Fact.MR, worldwide revenue from the sales of animal vaccines is calculated at US$ 15.62 billion for 2024. The Increasing prevalence of cattle and canine disorders is expected to drive global animal vaccine market growth at a CAGR of 9.1% to reach US$ 37.42 billion by 2034.

Rising investments in research and development initiatives by respective governments across the globe is positively influencing the demand for animal vaccines. In the recent past, there have been numerous instances of outbreaks of various contagious diseases, both among animals as well as their transmission to humans. Hence, emphasis on the development of advanced animal vaccines is gaining a major importance.

  • Centers for Disease Control and Prevention estimates that zoonotic is a prevalent disease across the globe and more than 6 out of 10 known contagious (infectious) diseases and 3 out of 4 new diseases are transmitted into humans from animals.

The recent COVID-19 pandemic can be purported to be an end product of zoonotic viral transmission. Given the fact that the novel coronavirus originated from bats, veterinarians were emphasizing on inoculating animal populations against the virus as well. This significantly widened growth prospects for the industry during this crisis. Coronavirus also infected the mink farms across Europe which further highlighted the need for introducing advanced animal vaccines. Thus, Corona can be concluded as a major booster leading to innovations in the animal vaccine sector.

Manufacturers of animal vaccines are also focusing more on creating awareness regarding the importance of animal vaccination. As the global food industry heavily relies on animals for milk and meat, the demand for various vaccines such as autogenous, flu, and aquaculture is expected to grow.

  • The North American animal vaccine market size is projected to reach US$ 15.35 billion by 2034.
  • Western Europe is estimated to hold 21% of the global animal vaccine market share in 2024.
Report Attributes Details
Animal Vaccine Market Size (2024E) US$ 15.62 Billion
Forecasted Market Value (2034F) US$ 37.42 Billion
Global Market Growth Rate (2024 to 2034) 9.1% CAGR
South Korea Market Value (2024E) US$ 610.6 Million
South Asia & Pacific Market Share (2034F) 22.6%
Subcutaneous Administration Type Vaccine Demand Growth Rate (2024 to 2034) 9.5% CAGR
Key Companies Profiled
  • Merck & Co. Inc.
  • Virbac
  • Biogenesis Bago
  • Indian Immunologicals Ltd.
  • CEVA Animal Health (Pty) Ltd.
  • Phibro Animal Health Corporation
  • Zoetis Inc.
  • NEOGEN Corporation
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Which Aspects are Pushing Demand for Animal Vaccines?

“Increasing Livestock Production Driving Need for Improved Vaccinations”

Growing livestock population and surge in the cattle diseases are some of the notable animal vaccine market trends. Animals are a vital source of milk, meat, food, protein, and other commercial products such as leather and wool, which necessitates a need to keep a track on their health.

Rabies, equine influenza virus and foot and mouth diseases are some of the prevalent animal disorders boosting the need for effective vaccines. Manufacturers are concentrating on producing effective vaccines that help in preventing the transmission of infectious agents in animals.

Rising food security concerns and increasing animal husbandry sector is escalating the demand for animal vaccines for the livestock population. Furthermore, the growing demand for animal products for food and clothing are boosting the growth in livestock production globally. Variation in food preferences due to changing lifestyles and population growth are also some of the other factors increasing the demand for livestock products, driving animal vaccine sales.

“Rising Prevalence of Contagious Diseases Bolstering Consumption of Animal Vaccines”

Emerging zoonotic diseases of both companion and livestock animals are a major threat to public health. The rising prevalence of zoonotic and other infectious diseases is potentially boosting the demand for next-gen animal vaccines. Zoonotic disease can be transmitted to humans, this risk is further leading to the production of advanced vaccines. In addition, the rapidly growing pet culture across the globe is contributing to the growth of emerging and exotic animal diseases creating ample opportunities for animal vaccine producers

Rising demand for animal protein is also contributing to high commercial animal food production. Furthermore, the possibility of world experiencing emerging disease outbreaks is high. Thus, the awareness for vaccinating animals is increasing.

What’s Hurting Revenue Growth of Animal Vaccine Producers?

“Lack of Awareness and Accessibility Primarily Hampering Widespread Adoption of Animal Immunizations”

Even though sales of animal vaccines are gaining traction, lack of awareness around some regions or among small scale animal farm holders is expected to lower their widespread adoption. The small scale animal farm holders might also deter the immunizations of animals due to high costs of vaccines or lack of accessibility. Several organizations and manufacturers across the globe are focusing on various tactics to increase adoption of animal vaccines, to boost their accessibility, and awareness.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Is Animal Vaccine Production a Profitable Business to Invest in for New Companies?

“Focus on Product Innovation and Differentiation Will Boost Market Reach”

Veterinary vaccine industry is witnessing a substantial rise in technological advancements. Recombinant DNA technology is one of the leading developments in the market. New companies entering the market should focus on innovations to succeed for long run. Innovations such as the development of plant-based vaccines are expected to show several advantages compared to conventional ones. Product innovations aid start-ups to build their position in the market. This also helps to attract a wider consumer base.

Country-wise Analysis

Why is the United States a Prime Market for Animal Vaccine Suppliers?

“Ongoing Developments in Veterinary Vaccines Set to Offer Lucrative Business Opportunities”

Attribute United States
Market Value (2024E) US$ 5.1 Billion
Growth Rate (2024 to 2034) 9.7% CAGR
Projected Value (2034F) US$ 12.86 Billion

The United States is the one of the most profitable markets for animal vaccine producers due to the presence of strong animal husbandry sector. The surge in pet culture, advancements in pet vaccines, and growing investments in the production of advanced vaccine delivery methods is expected to boost the market growth in the United States. Thus, advancements in veterinary science and biotechnology are set to boost the sales of animal vaccines in the United States.

What is the Demand Outlook for Animal Vaccines in Germany?

“Rising Pet Culture Increasing Consumption of Companion Animal Vaccines”

Germany is one of the high-growth potential markets in European region. This can be due to the presence of advanced pharmaceutical sector and advanced healthcare infrastructure. The country is also well known for extensive scientific research and innovations. The rising pet culture and growing prevalence of companion animal diseases is fuelling the demand for effective veterinary vaccines in Germany.

  • According to Statista report 2022, around 24% of Germans owned cats, 21% owned dogs, while 5% owned small animals.

What’s Driving Sales of Animal Vaccines in India?

“Presence of Robust Animal Husbandry and Commercial Aquaculture Sectors”

Attribute India
Market Value (2024E) US$ 882.2 Million
Growth Rate (2024 to 2034) 14.1% CAGR
Projected Value (2034F) US$ 3.3 Billion

India is a large market for animal vaccines in South Asia & Pacific region due to the presence of robust animal farming sector. Several government initiatives positively supporting the animal husbandry and commercial aquaculture sectors are creating ample opportunities for animal vaccine providers.

  • According to the Indian government, the country is the largest producer of milk across the globe.

Thus, ever-growing dairy sector and surge in the cattle production are contributing to animal vaccine market growth in India.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Analysis

Which Animal Category Accounts for High Usage of Vaccines?

“Rising Livestock Production Increasing Consumption of Animal Vaccines”

Attribute Livestock Animal Vaccines
Segment Value (2024E) US$ 10.23 Billion
Growth Rate (2024 to 2034) 8.9% CAGR
Projected Value (2034F) US$ 24.04 Billion

Rising livestock population particularly cattle, pig, poultry, and sheep across the globe are contributing to the outbreak of diseases. Farm holders are widely focusing on livestock production due to the increasing demand for milk, meat, protein, wool, and leather. Proper care for healthy growth of animals is leading to the increasing consumption of vaccines.

Respective governments across the globe are offering various initiatives supporting the awareness of animal vaccinations. Increasing prevalence rate of E.coli in various cattle categories is also boosting the demand for animal vaccines.

Which Vaccine Type is Most Widely Popular across the World?

“Long-Lasting Effect and Reduction in Mortality Rates Due to Attenuated Live Vaccines”

Attribute Attenuated Live Vaccines
Segment Value (2024E) US$ 5.49 Billion
Growth Rate (2024 to 2034) 9.4% CAGR
Projected Value (2034F) US$ 13.43 Billion

Live attenuation is not only the oldest vaccination method used in the veterinary field but now is also being used under trial for the development of additional applications. Thus, these products help in reducing the mortality rate by improving the life span of disease-affected animals. Attenuated live vaccines are more effective as they provides prolong protection against the infections.

Competitive Landscape

Key players in the animal vaccine market are capitalizing on respective governments supportive polices and initiatives across the globe to promote animal health. This support is contributing to the production of next-gen vaccine formulations against a wide variety of pathogens. Furthermore, industry leaders are also emphasizing on global expansions, mergers, acquisitions and collaborations to achieve a competitive edge.

  • In August 2020, Merck & Co., Inc. completed the acquisition of IdentiGEN. The company is focusing on studying DNA of animals for livestock. Through this acquisition, Merck intends to provide complete transparency to food processors, producers and retailers, regarding animal traceability solutions to ensure that good quality food is available to consumers.

Key Segments of Animal Vaccine Market Research

  • By Product :

    • Attenuated Live
    • Recombinant
    • DNA
    • Inactivated
    • Subunit
  • By Animal Type :

    • Livestock Animal Vaccines
    • Companion Animal Vaccines
  • By Route of Administration :

    • Subcutaneous Administration
    • Intranasal Administration
    • Intramuscular Administration
  • By Region :

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • Middle East & Africa

- FAQs -

How big is the animal vaccine market in 2024?

The global animal vaccine market is evaluated at US$ 15.62 billion in 2024.

What is the projected size of the animal vaccine market for 2034?

Sales of animal vaccines are forecasted to reach US$ 37.42 billion by 2034.

What is the estimated demand growth for animal vaccines?

Demand for animal vaccines is projected to rise at a CAGR of 9.1% through 2034.

Which East Asian country is an emerging market for animal vaccines?

South Korea is projected to account for 24.4% of the East Asia market share by 2034.

Which animal vaccine is most widely demanded?

Sales of livestock animal vaccines are forecasted to reach US$ 24.04 billion by 2034.

Who are the leading producers of animal vaccines?

Some of the prime manufacturers are Merck & Co. Inc., Zoetis Inc., and Boehringer Ingelheim International GmbH.

- Also of Interest -

Autogenous Vaccine for Aquaculture Market

Autogenous Vaccine for Aquaculture Market Study by Salmon, Tilapia, Bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Cyclopterus Lumpus, and Trout from 2024 to 2034

Flu Vaccine Market

Flu Vaccine Market Study by Trivalent Flu Vaccines and Quadrivalent Flu Vaccines in Intramuscular Injections, Nasal Sprays, and Intradermal Shots from 2024 to 2034

Autogenous Vaccine Market

Autogenous Vaccine Market Study by Bacterial Strain and Virus Strain for Veterinary Research Institutes, Livestock Farming Companies, and Veterinary Clinics & Hospitals from 2024 to 2034

Commercial Aquaculture Vaccine Market

Commercial Aquaculture Vaccine Market Study by Inactivated, Attenuated, Subunit, and DNA for Fish Farming Companies, Fish Veterinary Clinics, and Aquatic Research Institutes from 2024 to 2034

Animal Vaccine Market